Literature DB >> 32506292

Evaluation of effects of positive airway pressure treatment on retinal fiber thickness and visual pathways using optic coherence tomography and visual evoked potentials in the patients with severe obstructive sleep apnea syndrome.

Melike Batum1, Ayşın Kısabay2, Hüseyin Mayalı3, Tuğba Göktalay4, Emin Kurt3, Deniz Selçuki2, Hikmet Yılmaz2.   

Abstract

INTRODUCTION: Hypoxia during sleep in obstructive sleep apnea syndrome (OSAS) increases intracranial pressure, decreases cerebral perfusion pressure, and alters vascular supply to the optic nerve. Pattern visual evoked potential (pVEP) has revealed that it causes alterations in the optic nerve, and optic coherence tomography has shown that it causes alterations in the retinal and macular layers.
OBJECTIVES: To detect and compare possible alterations in macula and peripapillary retinal nerve fiber thickness (pRNFL) using OCT and in the optic nerve pathways using pVEP before and after positive airway pressure (PAP) in the patients with severe OSAS.
MATERIALS AND METHODS: Thirty patients who were diagnosed as having severe OSAS in the neurology-sleep outpatient clinic and 30 healthy control subjects were included in the study. Ophthalmic examinations were performed prior to (month 0) and after (month 6) PAP treatment, and pVEP (peak time [PT] and amplitude) and OCT parameters (peripapillary retinal-macular layers) were compared.
RESULTS: In the comparison between the severe OSAS (before treatment) and control groups, thinning was found in pRNFL (average, nasal, inferior) and in the macular layers (external and internal superior quadrants) (p < 0.05). pVEP investigation revealed increased PT in P100 and N145 waves and decreased amplitude of N75-P100 waves. In the comparisons before and after PAP treatment, a decrease in PT of N75 and P100 waves and increase in N75-P100 amplitudes were found. In the pRNFL, significant thickening was found in the layers with thinning before treatment, whereas no significant thickening was found in macular layers, except for the fovea. DISCUSSION: It was shown that PAP treatment in patients with severe OSAS prevents hypoxia without causing alterations in intraocular pressure and thus reduces inflammation and causes thickening in the pRNFL and macular layers.

Entities:  

Keywords:  Macula; Obstructive sleep apnea syndrome; Optic coherence tomography; Pattern visual evoked potential; Peripapillary retinal nerve fiber layer; Positive airway pressure treatment

Year:  2020        PMID: 32506292     DOI: 10.1007/s10792-020-01426-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  42 in total

Review 1.  Epidemiology of obstructive sleep apnea: a population health perspective.

Authors:  Terry Young; Paul E Peppard; Daniel J Gottlieb
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

2.  Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients.

Authors:  Margherita Sergi; Daniela Eva Salerno; Maurizio Rizzi; Mirella Blini; Arnaldo Andreoli; Dario Messenio; Marica Pecis; Giancarlo Bertoni
Journal:  J Glaucoma       Date:  2007-01       Impact factor: 2.503

Review 3.  The sleep apnea syndromes.

Authors:  C Guilleminault; A Tilkian; W C Dement
Journal:  Annu Rev Med       Date:  1976       Impact factor: 13.739

4.  Evaluation of the visual function in obstructive sleep apnea syndrome patients and normal-tension glaucoma by means of the multifocal visual evoked potentials.

Authors:  Jean-Claude Quintyn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-08       Impact factor: 3.117

5.  Floppy eyelid syndrome as an indicator of the presence of glaucoma in patients with obstructive sleep apnea.

Authors:  MaJesús Muniesa; Manuel Sánchez-de-la-Torre; Valentín Huerva; Marina Lumbierres; Ferran Barbé
Journal:  J Glaucoma       Date:  2014-01       Impact factor: 2.503

6.  Nonarteritic anterior ischemic optic neuropathy and obstructive sleep apnea.

Authors:  Gorkem Bilgin; Yaran Koban; Anthony C Arnold
Journal:  J Neuroophthalmol       Date:  2013-09       Impact factor: 3.042

7.  Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective.

Authors:  Won Lee; Swamy Nagubadi; Meir H Kryger; Babak Mokhlesi
Journal:  Expert Rev Respir Med       Date:  2008-06-01       Impact factor: 3.772

8.  Obstructive sleep apnoea prevalence in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Hatice Arda; Serife Birer; Murat Aksu; Sevda Ismailogullari; Sarper Karakucuk; Ertugrul Mirza; Koray Gumus; Ayse Oner
Journal:  Br J Ophthalmol       Date:  2012-11-30       Impact factor: 4.638

9.  Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea.

Authors:  K Palombi; E Renard; P Levy; C Chiquet; Ch Deschaux; J P Romanet; J L Pépin
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

10.  Mechanisms used to restore ventilation after partial upper airway collapse during sleep in humans.

Authors:  Amy S Jordan; Andrew Wellman; Raphael C Heinzer; Yu-Lun Lo; Karen Schory; Louise Dover; Shiva Gautam; Atul Malhotra; David P White
Journal:  Thorax       Date:  2007-04-05       Impact factor: 9.139

View more
  3 in total

Review 1.  Retinal microcirculation characteristics in obstructive sleep apnea/hypopnea syndrome evaluated by OCT-angiography: a literature review.

Authors:  Evita Evangelia Christou; Konstantinos Kostikas; Christoforos Asproudis; Paraskevas Zafeiropoulos; Maria Stefaniotou; Ioannis Asproudis
Journal:  Int Ophthalmol       Date:  2022-05-23       Impact factor: 2.031

2.  Macular and Optic Disc Parameters in Children with Amblyopic and Nonamblyopic Eyes under Optical Coherence Tomography Fundus Images.

Authors:  Dan Zhu; Qiang Sun; Hong Yang; Yangcheng Zou; Chunmei Liu; Yan Xu
Journal:  Comput Math Methods Med       Date:  2022-06-15       Impact factor: 2.809

Review 3.  Sleep and eye disease: A review.

Authors:  Samantha S Y Lee; Vinay K Nilagiri; David A Mackey
Journal:  Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 4.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.